Go Pro

Inspire Medical Systems (INSP) Competitors

Inspire Medical Systems logo
$72.70 +4.58 (+6.73%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$73.00 +0.29 (+0.40%)
As of 09/11/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

INSP vs. MMED, TFX, HAE, LIVN, and ITGR

Should you buy Inspire Medical Systems stock or one of its competitors? Inspire Medical Systems's main competitors and comparable companies include MiniMed Group (MMED), Teleflex (TFX), Haemonetics (HAE), LivaNova (LIVN), and Integer (ITGR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Inspire Medical Systems compare to MiniMed Group?

MiniMed Group (NASDAQ:MMED) and Inspire Medical Systems (NYSE:INSP) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings, dividends and media sentiment.

94.9% of Inspire Medical Systems shares are owned by institutional investors. 0.0% of MiniMed Group shares are owned by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Inspire Medical Systems had 1 more articles in the media than MiniMed Group. MarketBeat recorded 4 mentions for Inspire Medical Systems and 3 mentions for MiniMed Group. MiniMed Group's average media sentiment score of 1.56 beat Inspire Medical Systems' score of 1.26 indicating that MiniMed Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MiniMed Group
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Inspire Medical Systems
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Inspire Medical Systems has a net margin of 15.03% compared to MiniMed Group's net margin of 0.00%. Inspire Medical Systems' return on equity of 8.64% beat MiniMed Group's return on equity.

Company Net Margins Return on Equity Return on Assets
MiniMed GroupN/A N/A N/A
Inspire Medical Systems 15.03%8.64%7.45%

Inspire Medical Systems has lower revenue, but higher earnings than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MiniMed Group$3.10B2.04-$333M-$0.68N/A
Inspire Medical Systems$911.98M2.30$145.42M$4.6215.74

MiniMed Group currently has a consensus target price of $23.77, indicating a potential upside of 5.64%. Inspire Medical Systems has a consensus target price of $66.50, indicating a potential downside of 8.53%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts plainly believe MiniMed Group is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MiniMed Group
1 Sell rating(s)
2 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.75
Inspire Medical Systems
3 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
2.21

Summary

Inspire Medical Systems beats MiniMed Group on 11 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to Teleflex?

Inspire Medical Systems (NYSE:INSP) and Teleflex (NYSE:TFX) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, earnings, profitability and institutional ownership.

Inspire Medical Systems has higher earnings, but lower revenue than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M2.30$145.42M$4.6215.74
Teleflex$1.99B2.78-$905.64M-$23.29N/A

In the previous week, Teleflex had 2 more articles in the media than Inspire Medical Systems. MarketBeat recorded 6 mentions for Teleflex and 4 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.26 beat Teleflex's score of 0.45 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Teleflex
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Inspire Medical Systems has a net margin of 15.03% compared to Teleflex's net margin of -39.67%. Teleflex's return on equity of 11.93% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems15.03% 8.64% 7.45%
Teleflex -39.67%11.93%5.44%

Inspire Medical Systems presently has a consensus target price of $66.50, suggesting a potential downside of 8.53%. Teleflex has a consensus target price of $152.90, suggesting a potential upside of 16.85%. Given Teleflex's stronger consensus rating and higher possible upside, analysts clearly believe Teleflex is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
3 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
2.21
Teleflex
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.42

94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 2.2% of Inspire Medical Systems shares are held by insiders. Comparatively, 0.7% of Teleflex shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Inspire Medical Systems has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market. Comparatively, Teleflex has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market.

Summary

Teleflex beats Inspire Medical Systems on 9 of the 17 factors compared between the two stocks.

How does Inspire Medical Systems compare to Haemonetics?

Haemonetics (NYSE:HAE) and Inspire Medical Systems (NYSE:INSP) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends and media sentiment.

Haemonetics has a beta of 0.54, indicating that its share price is 46% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.7, indicating that its share price is 30% less volatile than the broader market.

Inspire Medical Systems has lower revenue, but higher earnings than Haemonetics. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Haemonetics$1.33B3.50$97.31M$2.0450.32
Inspire Medical Systems$911.98M2.30$145.42M$4.6215.74

Inspire Medical Systems has a net margin of 15.03% compared to Haemonetics' net margin of 7.12%. Haemonetics' return on equity of 27.55% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Haemonetics7.12% 27.55% 9.65%
Inspire Medical Systems 15.03%8.64%7.45%

99.7% of Haemonetics shares are owned by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are owned by institutional investors. 2.1% of Haemonetics shares are owned by company insiders. Comparatively, 2.2% of Inspire Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Haemonetics currently has a consensus price target of $99.78, indicating a potential downside of 2.80%. Inspire Medical Systems has a consensus price target of $66.50, indicating a potential downside of 8.53%. Given Haemonetics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Haemonetics is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Haemonetics
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73
Inspire Medical Systems
3 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
2.21

In the previous week, Haemonetics and Haemonetics both had 4 articles in the media. Inspire Medical Systems' average media sentiment score of 1.26 beat Haemonetics' score of 0.79 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Haemonetics
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspire Medical Systems
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Haemonetics beats Inspire Medical Systems on 9 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to LivaNova?

Inspire Medical Systems (NYSE:INSP) and LivaNova (NASDAQ:LIVN) are both mid-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

Inspire Medical Systems has a net margin of 15.03% compared to LivaNova's net margin of 12.82%. LivaNova's return on equity of 16.35% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems15.03% 8.64% 7.45%
LivaNova 12.82%16.35%7.76%

Inspire Medical Systems has higher earnings, but lower revenue than LivaNova. Inspire Medical Systems is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M2.30$145.42M$4.6215.74
LivaNova$1.39B3.10-$242.47M$3.3823.13

94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 2.2% of Inspire Medical Systems shares are held by company insiders. Comparatively, 0.4% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Inspire Medical Systems currently has a consensus target price of $66.50, suggesting a potential downside of 8.53%. LivaNova has a consensus target price of $84.13, suggesting a potential upside of 7.60%. Given LivaNova's stronger consensus rating and higher possible upside, analysts plainly believe LivaNova is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
3 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
2.21
LivaNova
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.55

Inspire Medical Systems has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

In the previous week, LivaNova had 3 more articles in the media than Inspire Medical Systems. MarketBeat recorded 7 mentions for LivaNova and 4 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.26 beat LivaNova's score of 1.00 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

LivaNova beats Inspire Medical Systems on 11 of the 17 factors compared between the two stocks.

How does Inspire Medical Systems compare to Integer?

Inspire Medical Systems (NYSE:INSP) and Integer (NYSE:ITGR) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

Inspire Medical Systems has higher earnings, but lower revenue than Integer. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M2.30$145.42M$4.6215.74
Integer$1.85B2.31$102.81M$3.6634.44

Inspire Medical Systems presently has a consensus price target of $66.50, suggesting a potential downside of 8.53%. Integer has a consensus price target of $109.86, suggesting a potential downside of 12.86%. Given Inspire Medical Systems' stronger consensus rating and higher possible upside, equities research analysts clearly believe Inspire Medical Systems is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
3 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
2.21
Integer
0 Sell rating(s)
13 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.07

In the previous week, Integer had 5 more articles in the media than Inspire Medical Systems. MarketBeat recorded 9 mentions for Integer and 4 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.26 beat Integer's score of 0.25 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 2.2% of Inspire Medical Systems shares are held by insiders. Comparatively, 1.1% of Integer shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Inspire Medical Systems has a beta of 0.7, meaning that its share price is 30% less volatile than the broader market. Comparatively, Integer has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market.

Inspire Medical Systems has a net margin of 15.03% compared to Integer's net margin of 6.97%. Integer's return on equity of 12.79% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems15.03% 8.64% 7.45%
Integer 6.97%12.79%6.48%

Summary

Inspire Medical Systems beats Integer on 11 of the 17 factors compared between the two stocks.

Get Inspire Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INSP vs. The Competition

MetricInspire Medical SystemsHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$2.11B$5.48B$7.16B$23.37B
Dividend YieldN/A1.80%2.57%3.56%
P/E Ratio15.7425.09274.9428.72
Price / Sales2.3071.54686.5720.04
Price / Cash25.4932.5776.6534.17
Price / Book2.705.9710.334.74
Net Income$145.42M$150.75M$3.50B$1.07B
7 Day Performance15.42%-2.83%-3.32%-2.00%
1 Month Performance24.84%-3.73%-0.53%-3.20%
1 Year Performance-9.44%9.38%23.51%10.51%

Inspire Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INSP
Inspire Medical Systems
3.2479 of 5 stars
$72.70
+6.7%
$66.50
-8.5%
-9.4%$2.11B$911.98M15.741,333
MMED
MiniMed Group
1.5125 of 5 stars
$23.28
flat
$23.77
+2.1%
N/A$6.55B$3.10BN/A2,800
TFX
Teleflex
4.4247 of 5 stars
$138.21
-0.1%
$152.90
+10.6%
+0.3%$5.86B$1.99BN/A15,500
HAE
Haemonetics
1.7943 of 5 stars
$103.00
+0.1%
$99.78
-3.1%
+96.5%$4.68B$1.33B50.493,009
LIVN
LivaNova
2.8814 of 5 stars
$81.92
flat
$84.13
+2.7%
+39.1%$4.51B$1.39B24.243,300

Related Companies and Tools


This page (NYSE:INSP) was last updated on 9/13/2026 by MarketBeat.com Staff.
From Our Partners